Nafion-HÒ-catalyzed synthesis of polyhydroquinolines
1679
125.4, 125.6, 126.9, 127.9, 143.2, 146.5, 150.5, 167.8,
196.4 ppm.
X-ray crystallography
X-ray diffraction data were collected using an Enraf–No-
nius CAD4 diffractometer. The structure of compound 5l
was determined by a direct method using the program
SHELXS 97 and difference Fourier calculation. The
coordinates of nonhydrogen atoms were refined aniso-
tropically using the program SHELXL 97 [66]. The
positions of hydrogen atoms were determined from dif-
ference Fourier maps and were included in the final cycles
of refinement using isotropic temperature factors of the
nonhydrogen atoms to which they were attached. The final
R-factor for observed 7,518 reflections [I C 2r(I)] was
0.1824. The atomic scattering factors used in these calcu-
lations were those of Cromer and Mann [67] for
nonhydrogen atoms and of Stewart et al. [68] for hydrogen
atoms.
Fig. 4 ORTEP plot of compound 5l at the 50% ellipsoidal
probability
The obtained catalyst had the same catalytic activity as the
fresh catalyst.
Ethyl 1,4,5,6,7,8-hexahydro-4-(3-hydroxyphenyl)-2,7,7-tri-
methyl-5-oxoquinoline-3-carboxylate (5f, C21H25NO4)
IR (Nujol): m = 3,245, 2,959, 1,600, 1,453, 1,379, 1,267,
Crystallographic data for the structure 5l have been
deposited with the Cambridge Crystallographic Data Cen-
tre as supplementary publication number CCDC 796332.
1,149, 707 cm-1
;
1H NMR (DMSO-d6, 400 MHz):
d = 0.90 (s, 3H, CH3), 1.02 (s, 3H, CH3), 1.16 (t, 3H,
J = 7.04 Hz, CH3), 2.13–2.29 (m, 4H, 2 9 CH2), 2.32 (s,
3H, CH3), 4.02 (q, 2H, J = 7.4 Hz, CH2), 4.96 (s, 1H, CH–
Ar), 5.85 (br s, 1H, NH), 6.75–6.99 (m, 4H, Ar–H), 7.81 (s,
1H, OH) ppm; 13C NMR (DMSO-d6, 100 MHz): d = 13.4,
18.4, 19.8, 27.3, 28.7, 32.3, 35.6, 50.9, 58.8, 100.4, 105.1,
112.0, 112.9, 114.9, 119.3, 128.2, 144.3, 148.5, 149.3,
167.4, 194.9 ppm.
Acknowledgments Ritika Chauhan is grateful to UGC (University
Grants Commission) for providing junior research fellowship. We
express our thanks to the Director of University Science and Instru-
mentation Centre, University of Delhi, Delhi, for providing the
spectral data and also acknowledge the Head of the Biophysics
Department, All India Institute of Medical Sciences, New Delhi, for
carrying out the X-ray studies.
Ethyl 1,4,5,6,7,8-hexahydro-4-(2-hydroxy-3-methoxy-
phenyl)-2-methyl-5-oxoquinoline-3-carboxylate
(5j, C20H23NO5)
References
1. Guillena G, Ramon DJ, Yus M (2007) Tetrahedron Asymmetry
18:693
2. Domling A (2006) Chem Rev 106:17
3. Simon C, Constantieux T, Rodrigeuz J (2004) Eur J Org Chem
4957
4. Domling A, Ugi I (2000) Angew Chem Int Ed 39:3168
5. Ramon DJ, Yus M (2005) Angew Chem Int Ed 44:1602
6. Mauzerall D, Westheimer FH (1955) J Am Chem Soc 77:2261
7. Baraldi PG, Budriesi R, Cacciari B, Chiarini A, Garuti L,
Giovanninetti G, Leoni A, Roberti M (1992) Collect Czech Chem
Commun 57:169
IR (Nujol): m = 3,342, 2,946, 1,733, 1,693, 1,607, 1,523,
1,390, 1,078 cm-1; 1H NMR (CDCl3, 400 MHz): d = 1.21
(t, 3H, J = 7.32 Hz, CH3), 1.88–2.27 (m, 6H, 3 9 CH2),
2.47 (s, 3H, CH3), 3.85 (s, 3H, OCH3), 4.10 (q, 2H,
J = 7.3 Hz, CH2), 5.17 (s, 1H, CH–Ar), 6.14 (br s, 1H,
NH), 6.69–6.79 (m, 3H, Ar–H), 9.26 (s, 1H, OH) ppm; 13
C
NMR (CDCl3, 100 MHz): d = 14.0, 19.5, 21.2, 25.4, 27.7,
29.7, 30.3, 36.2, 43.6, 55.8, 60.3, 81.2, 110.2, 120.8, 140.3,
148.7, 158.7, 169.9, 194.9 ppm.
8. Di Stilo A, Visentin S, Cena C, Gasco AM, Ermondi G, Gasco A
(1998) J Med Chem 41:5393
Ethyl 1,4,5,6,7,8-hexahydro-4-(1-naphthyl)-2-methyl-5-
oxoquinoline-3-carboxylate (5l, C23H23NO3)
9. Kawase M, Shah A, Gaveriya H, Motohashi N, Sakagami H,
Varga A, Molnar J (2002) Bioorg Med Chem 10:1051
10. Suarez M, Verdecia Y, Illescas B, Martinez-Alvarez R, Alvarez
A, Ochoa E, Seoane C, Kayali N, Martin N (2003) Tetrahedron
59:9179
11. Shan R, Velazquez C, Knaus EE (2004) J Med Chem 47:254
12. Bossert F, Meyer H, Wehinger E (1981) Angew Chem Int Ed
20:762
IR (Nujol): m = 3,292, 3,082, 2,952, 1,696, 1,609, 1,487,
1,379, 1,222 cm-1; 1H NMR (CDCl3, 400 MHz): d = 0.87
(t, 3H, J = 7.32 Hz, CH3), 1.86–2.27 (m, 6H, 3 9 CH2),
2.40 (s, 3H, CH3), 3.88 (q, 2H, J = 7.08 Hz, CH2), 5.84 (s,
1H, CH–Ar), 6.21 (br s, 1H, NH), 7.33–7.73 (m, 7H,
naphthyl) ppm; 13C NMR (CDCl3, 100 MHz): d = 14.1,
19.1, 21.0, 27.1, 31.8, 37.1, 59.8, 107.7, 114.5, 125.3,
13. Takenaka T, Usuda S, Nomura T, Maeno H, Sado T (1976)
Arzneim Forsch 26:2172
14. Julius S (1988) J Cardiovasc Pharmacol 12:S27
123